Clinical trialNCT06850623RecruitingPhase 2Interventional

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

SponsorEXACT Therapeutics ASEnrollment25Locally Advanced Pancreatic Adenocarcinoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom

Cambridge Cancer Trials Centre-Addenbrooke'S Hospital
Cambridge, Cambridge, United Kingdom
Kiran Purushothaman, MD
Recruiting
Gary Weston Centre- Imperial College Healthcare- Du Cane Road
Hammersmith, London, United Kingdom
Harpreet Wasan, Professor: MBBS:MRCP
Recruiting
the Royal Marsden- Downs Road
Sutton, Surrey, United Kingdom
Hazel Lote, MD
Recruiting

United States

Honorhealth Research Institute
Scottsdale, Arizona, United States
Erkut Borazanci, MD
Recruiting
Stanford Cancer Center Palo Alto
Stanford, California, United States
Pejman Ghanouni, MD:PhD
Recruiting
Beth Israel Deaconess Medical Center - Division of Hematology/oncology
Boston, Massachusetts, United States
Andrea Bullock, MD
Recruiting
Henry Ford Centre
Detroit, Michigan, United States
Maria Diab, MD
Recruiting
Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Babar Bashir, MD
Recruiting
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Paul Renz, DO
Recruiting
Brown University Cancer Institute
Providence, Rhode Island, United States
Alexander Raufi, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Modified FOLFIRINOX

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jun 2025
Primary completion: 15 Dec 2026
Completion: 15 Jul 2027
Last update posted: 3 Apr 2026
Registered enrollment: 25
Registry id: NCT06850623

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.